Skip to main content
IOVA logo

IOVA · Iovance Biotherapeutics, Inc. · Short Interest

Track IOVA — free
$14.86 +0.65 (+4.57%) At close · Oct 20
Market Cap
$6.73B
Shares
452.97M
Volume · Oct 20 9.75M Avg daily vol (3M) 16.66M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

IOVA Latest Reported Short Interest

FINRA reported 64,827,030 IOVA shares sold short as of the September 30, 2026 settlement date, a decrease of 22,300,841 shares. Days to cover was 2.83 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

IOVA Short Interest Forecast

Equibles' model estimates 59,639,659 shares sold short for the October 15, 2026 settlement, -8.0% versus the latest reported position, with a likely range of 52,363,113 to 66,526,078 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 High confidence 84% chance it falls
59,639,659 -8.0% vs reported
Likely range 52,363,113 to 66,526,078 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
67/100
Short interest 14.3% of shares — P94 Days to cover 2.8 — P47 Price vs VWAP +59.4% — P100 Short-volume trend -5.9% — P30 Short interest change -25.6% — P12 Worst FTD 0.12% of shares — P85

Positioning score 66.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-21 06:17 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 64,827,030 87,127,871 -22,300,841 2.83
2026-09-15 87,127,871 88,138,991 -1,011,120 7.43
2026-08-31 88,138,991 102,940,590 -14,801,599 5.28
2026-08-14 102,940,590 99,975,709 +2,964,881 4.79
2026-07-31 99,975,709 99,892,938 +82,771 6.28
2026-07-15 99,892,938 100,526,623 -633,685 5.91
2026-06-30 100,526,623 103,489,642 -2,963,019 7.10
2026-06-15 103,489,642 104,249,751 -760,109 7.90
2026-05-29 104,249,751 106,608,353 -2,358,602 8.19
2026-05-15 106,608,353 114,711,667 -8,103,314 6.00
2026-04-30 114,711,667 108,804,045 +5,907,622 9.15
2026-04-15 108,804,045 110,832,243 -2,028,198 6.54
2026-03-31 110,832,243 115,070,206 -4,237,963 9.47
2026-03-13 115,070,206 130,927,595 -15,857,389 4.98
2026-02-27 130,927,595 131,334,639 -407,044 7.26
2026-02-13 131,334,639 105,255,004 +26,079,635 14.61
2026-01-30 105,255,004 117,099,153 -11,844,149 7.57
2026-01-15 117,099,153 119,070,866 -1,971,713 10.13
2025-12-31 119,070,866 120,342,810 -1,271,944 8.86
2025-12-15 120,342,810 118,939,462 +1,403,348 12.67
2025-11-28 118,939,462 115,733,068 +3,206,394 11.83
2025-11-14 115,733,068 95,415,882 +20,317,186 4.04
2025-10-31 95,415,882 83,612,571 +11,803,311 7.42

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1425205 CUSIP 462260100 13F (30d) 28 filings 28 filers Visit website Investor relations